A Genome-wide Gene-Expression Analysis and Database in Transgenic Mice during Development of Amyloid or Tau Pathology

Abstract

We provide microarray data comparing genome-wide differential expression and pathology throughout life in four lines of "amyloid" transgenic mice (mutant human APP, PSEN1, or APP/PSEN1) and "TAU" transgenic mice (mutant human MAPT gene). Microarray data were validated by qPCR and by comparison to human studies, including genome-wide association study (GWAS) hits. Immune gene expression correlated tightly with plaques whereas synaptic genes correlated negatively with neurofibrillary tangles. Network analysis of immune gene modules revealed six hub genes in hippocampus of amyloid mice, four in common with cortex. The hippocampal network in TAU mice was similar except that Trem2 had hub status only in amyloid mice. The cortical network of TAU mice was entirely different with more hub genes and few in common with the other networks, suggesting reasons for specificity of cortical dysfunction in FTDP17. This Resource opens up many areas for investigation. All data are available and searchable at http://www.mouseac.org.

A molecular network of the aging brain implicatesINPPL1andPLXNB1in Alzheimer’s disease

“…The module preservation statistic (called "z-summary") combines multiple metrics that assess the conservation of co-expression patterns within a given module in a second (validation) dataset. As validation data, we employed four datasets: a) microarray gene expression data from cortex (DLPFC) from a previous study by Zhang and colleagues 46 , b) microarray gene expression data from mouse brain from a previous study by Matarin and colleagues 48 , c) an independent test dataset from the ROSMAP study (unpublished, data available from Synapse doi:10.7303/syn3388564) d) histone modification data (H3K9Ac chromatin immunoprecipitation followed by sequencing, unpublished, available doi:10.7303/syn4896408). We summarize the analyses of these data below.…”

PAM forms an atypical SCF ubiquitin ligase complex that ubiquitinates and degrades NMNAT2

“…NAD is an essential co-enzyme for several biological process, such as cell death, energy metabolism and calcium mobilization. NMNAT2 is highly expressed in the brain, and along with axon protection following injury (44)(45)(46)(47)(48)(49) is implicated in neurodegenerative disease (50)(51)(52)(53). While functional genetics indicate PHR proteins can inhibit NMNAT2, the biochemical mechanism by which this occurs remains untested.…”

Alzheimer’s disease: where next for anti-amyloid therapies?

“…2016). Genetic evidence for this complexity comes from the identification of microglial response genes as risk loci for Alzheimer's disease (Matarin et al 2015) Guest Editorial 3 At a theoretical level, the negative outcome of anti-amyloid therapy was not excluded, even without putting the causal contribution of Aβ to AD into question (Karran et al 2011). In one disease scenario, Aβ was proposed as a driver of the disease process.…”